Tags

Type your tag names separated by a space and hit enter

The ACTwatch project: methods to describe anti-malarial markets in seven countries.
Malar J. 2011 Oct 31; 10:325.MJ

Abstract

BACKGROUND

Policy makers, governments and donors are faced with an information gap when considering ways to improve access to artemisinin-based combination therapy (ACT) and malaria diagnostics including rapid diagnostic tests (RDTs). To help address some of these gaps, a five-year multi-country research project called ACTwatch was launched. The project is designed to provide a comprehensive picture of the anti-malarial market to inform national and international anti-malarial drug policy decision-making.

METHODS

The project is being conducted in seven malaria-endemic countries: Benin, Cambodia, the Democratic Republic of Congo, Madagascar, Nigeria, Uganda and Zambia from 2008 to 2012.ACTwatch measures which anti-malarials are available, where they are available and at what price and who they are used by. These indicators are measured over time and across countries through three study components: outlet surveys, supply chain studies and household surveys. Nationally representative outlet surveys examine the market share of different anti-malarials passing through public facilities and private retail outlets. Supply chain research provides a picture of the supply chain serving drug outlets, and measures mark-ups at each supply chain level. On the demand side, nationally representative household surveys capture treatment seeking patterns and use of anti-malarial drugs, as well as respondent knowledge of anti-malarials.

DISCUSSION

The research project provides findings on both the demand and supply side determinants of anti-malarial access. There are four key features of ACTwatch. First is the overlap of the three study components where nationally representative data are collected over similar periods, using a common sampling approach. A second feature is the number and diversity of countries that are studied which allows for cross-country comparisons. Another distinguishing feature is its ability to measure trends over time. Finally, the project aims to disseminate findings widely for decision-making.

CONCLUSIONS

ACTwatch is a unique multi-country research project that threads together anti-malarial supply and consumer behaviour to provide an evidence base to policy makers that can help determine where interventions may positively impact access to and use of quality-assured ACT and RDTs. Because of its ability to detect change over time, it is well suited to monitor the effects of policy or intervention developments in a country.

Authors+Show Affiliations

Malaria & Child Survival Department, Population Services International, P,O, Box 43640-00800, Nairobi, Kenya, Africa. tshewchuk@psi.orgNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22039780

Citation

Shewchuk, Tanya, et al. "The ACTwatch Project: Methods to Describe Anti-malarial Markets in Seven Countries." Malaria Journal, vol. 10, 2011, p. 325.
Shewchuk T, O'Connell KA, Goodman C, et al. The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malar J. 2011;10:325.
Shewchuk, T., O'Connell, K. A., Goodman, C., Hanson, K., Chapman, S., & Chavasse, D. (2011). The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malaria Journal, 10, 325. https://doi.org/10.1186/1475-2875-10-325
Shewchuk T, et al. The ACTwatch Project: Methods to Describe Anti-malarial Markets in Seven Countries. Malar J. 2011 Oct 31;10:325. PubMed PMID: 22039780.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The ACTwatch project: methods to describe anti-malarial markets in seven countries. AU - Shewchuk,Tanya, AU - O'Connell,Kathryn A, AU - Goodman,Catherine, AU - Hanson,Kara, AU - Chapman,Steven, AU - Chavasse,Desmond, Y1 - 2011/10/31/ PY - 2011/08/02/received PY - 2011/10/31/accepted PY - 2011/11/2/entrez PY - 2011/11/2/pubmed PY - 2012/2/9/medline SP - 325 EP - 325 JF - Malaria journal JO - Malar J VL - 10 N2 - BACKGROUND: Policy makers, governments and donors are faced with an information gap when considering ways to improve access to artemisinin-based combination therapy (ACT) and malaria diagnostics including rapid diagnostic tests (RDTs). To help address some of these gaps, a five-year multi-country research project called ACTwatch was launched. The project is designed to provide a comprehensive picture of the anti-malarial market to inform national and international anti-malarial drug policy decision-making. METHODS: The project is being conducted in seven malaria-endemic countries: Benin, Cambodia, the Democratic Republic of Congo, Madagascar, Nigeria, Uganda and Zambia from 2008 to 2012.ACTwatch measures which anti-malarials are available, where they are available and at what price and who they are used by. These indicators are measured over time and across countries through three study components: outlet surveys, supply chain studies and household surveys. Nationally representative outlet surveys examine the market share of different anti-malarials passing through public facilities and private retail outlets. Supply chain research provides a picture of the supply chain serving drug outlets, and measures mark-ups at each supply chain level. On the demand side, nationally representative household surveys capture treatment seeking patterns and use of anti-malarial drugs, as well as respondent knowledge of anti-malarials. DISCUSSION: The research project provides findings on both the demand and supply side determinants of anti-malarial access. There are four key features of ACTwatch. First is the overlap of the three study components where nationally representative data are collected over similar periods, using a common sampling approach. A second feature is the number and diversity of countries that are studied which allows for cross-country comparisons. Another distinguishing feature is its ability to measure trends over time. Finally, the project aims to disseminate findings widely for decision-making. CONCLUSIONS: ACTwatch is a unique multi-country research project that threads together anti-malarial supply and consumer behaviour to provide an evidence base to policy makers that can help determine where interventions may positively impact access to and use of quality-assured ACT and RDTs. Because of its ability to detect change over time, it is well suited to monitor the effects of policy or intervention developments in a country. SN - 1475-2875 UR - https://www.unboundmedicine.com/medline/citation/22039780/The_ACTwatch_project:_methods_to_describe_anti_malarial_markets_in_seven_countries_ L2 - https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-10-325 DB - PRIME DP - Unbound Medicine ER -